Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 46 , ISSUE 2 ( April-June, 2012 ) > List of Articles

MEETING REPORT

Hematopoietic Stem Cell Applications: Past, Present and Future

Subhash Varma, Deepesh P Lad

Citation Information : Varma S, Lad DP. Hematopoietic Stem Cell Applications: Past, Present and Future. J Postgrad Med Edu Res 2012; 46 (2):69-74.

DOI: 10.5005/jp-journals-10028-1016

Published Online: 01-03-2014

Copyright Statement:  Copyright © 2012; The Author(s).


Abstract

Key messages

Hematopoietic stem cells possess the characteristics of self renewal, differentiation, mobilization and apoptosis.

The transfer of hematopoietic stem cells to rescue a recipient's hematopoiesis, who has received conditioning with high dose chemotherapy and/or total body irradiation, constitutes hematopoietic stem cell transplantation (HSCT).

Hematopoietic stem cells can be obtained from the bone marrow, peripheral blood or umbilical cord blood.

Autologous HSCT involves the infusion of one's own hematopoietic stem cells. An allogeneic HSCT involves the infusion of hematopoietic stem cells from another individual.

Depending on the HLA match, the HSCT is of following types: Syngeneic, matched related, matched unrelated and haploidentical.

Patient selection and the timing of transplant are the most important factors determining transplant outcomes.

Hematopoietic stem cells and umbilical cord stem cells have applications in regenerative medicine as shown in preclinical and early clinical studies.

How to cite this article

Lad DP, Malhotra P, Varma S. Hematopoietic Stem Cell Applications: Past, Present and Future. J Postgrad Med Edu Res 2012;46(2):69-74.


PDF Share
  1. Stemness: Definition, criteria and standards. In: Lanza R, Gearhart J, Hogan B, et al. Handbook of stem cells. Amsterdam: Elsevier 2004;1:25
  2. Hematopoietic stem cells: The paradigmatic tissue-specific stem cell. Am J Pathol 2006; 169:338-46.
  3. Growth and continued function of rat marrow cells in X-radiated mice. Cancer Res 1956;16:258-61.
  4. Cytological identification of radiation chimeras. Nature 1956;177:452-54.
  5. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957;257:491-96.
  6. Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest 1959;38:1709-16.
  7. Immunological reconstitution of sex linked lymphopenic immunological deficiency. Lancet 1968;2:1366-69.
  8. Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia. Blood 1970;35: 741-50.
  9. An onsite audit of the South African trial of high dose chemotherapy for metastatic breast cancer and associated publications. J Clin Oncol 2001;19: 2771-77.
  10. Transplantation of bone marrow as compared with peripheral blood stem cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001;344:175-81.
  11. Selling bone marrow–Flynn v Holder. N Engl J Med 2012;366:296-97.
  12. Banking on cord blood stem cells. Nat Rev Cancer 2008;8:555-63.
  13. Collection and preservation of cord blood for personal use. Biol Blood Marrow transplant 2008;14:356-63.
  14. Current use and outcome of hematopoietic stem cell transplantation: Center for International Blood and Marrow Transplant Research (CIBMTR). Summary Slides 2011.
  15. Preliminary observations on the treatment of post-irradiation hematopoietic depression in man by the infusion of stored autologous bone marrow. Ann Intern Med 1958;49:973-86.
  16. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978;52:85-95.
  17. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non-Hodkin's lymphoma. N Engl J med 1995;333:1540-45.
  18. Aggressive conventional chemotherapy compared with high dose chemotherapy with autologous hematopoietic stem cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomized trial. Lancet 2002;359:2065-71.
  19. Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomized trial. Lancet 1993;341:1051-54.
  20. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996;335:91-97.
  21. Bone marrow transplantation in sickle cell anemia. Curr Opin Oncol 2001;13:85-90.
  22. Hematopoietic cell transplantation for immunodeficiency diseases. In: Appelbaum F, Froman S, Blume KG, Thomas ED (Eds). Hematopoietic cell transplantation (4th ed). Malden, MA: Blackwell Science 2004;1430-38.
  23. Outome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: A report from the European group for blood and marrow transplantation (EBMT). Haematologica 2007;92:11-18.
  24. Hematopoietic stem cell transplantation for myelodysplastic syndrome: A review. Semin Oncol 2011;38:693-704.
  25. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: An evidence-based review. Biol Blood Marrow Transplant 2008;14:137-80.
  26. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: Update of the 2006 evidence-based review. Biol Blood Marrow Transplant 2012;18:18-36.
  27. Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: Update of the 2005 evidence-based review. Biol Blood Marrow Transplant 2012;18:505-22.
  28. Chronic leukemia working party of the EBMT. Indications for allogeneic stem cell transplantation in CLL: The EBMT transplant consensus. Leukemia 2007;21:12-17.
  29. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-21.
  30. Future of cord blood for non-oncology uses. Bone marrow transplantation 2009;44:683-97.
  31. Non-hematological uses of cord blood stem cells. Br J Haematol 2009;147:177-84.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.